You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

EVOXAC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Evoxac patents expire, and what generic alternatives are available?

Evoxac is a drug marketed by Cosette and is included in one NDA.

The generic ingredient in EVOXAC is cevimeline hydrochloride. There are four drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cevimeline hydrochloride profile page.

Drug patent expirations by year for EVOXAC
Drug Prices for EVOXAC

See drug prices for EVOXAC

Recent Clinical Trials for EVOXAC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Roxane LaboratoriesEarly Phase 1
American Academy of Otolaryngology-Head and Neck Surgery FoundationPhase 4
Duke UniversityPhase 4

See all EVOXAC clinical trials

Pharmacology for EVOXAC
Anatomical Therapeutic Chemical (ATC) Classes for EVOXAC
Paragraph IV (Patent) Challenges for EVOXAC
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
EVOXAC Capsules cevimeline hydrochloride 30 mg 020989 1 2009-02-27

US Patents and Regulatory Information for EVOXAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette EVOXAC cevimeline hydrochloride CAPSULE;ORAL 020989-002 Jan 11, 2000 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for EVOXAC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cosette EVOXAC cevimeline hydrochloride CAPSULE;ORAL 020989-002 Jan 11, 2000 ⤷  Try a Trial ⤷  Try a Trial
Cosette EVOXAC cevimeline hydrochloride CAPSULE;ORAL 020989-002 Jan 11, 2000 ⤷  Try a Trial ⤷  Try a Trial
Cosette EVOXAC cevimeline hydrochloride CAPSULE;ORAL 020989-002 Jan 11, 2000 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for EVOXAC

See the table below for patents covering EVOXAC around the world.

Country Patent Number Title Estimated Expiration
Canada 2099970 COMPOSE POUR LE TRAITEMENT DU SYNDROME DE SJOEGREN (COMPOSITION FOR CURING SJOEGREN SYNDROME DISEASE) ⤷  Try a Trial
South Africa 8608369 ⤷  Try a Trial
Canada 2152420 ⤷  Try a Trial
Australia 4181993 ⤷  Try a Trial
Japan H0725767 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.